Simona Colantonio is an expert in mass spectrometry applied to biologically relevant molecules. She received her PhD in Pharmaceutical Sciences from la Sapienza University of Rome, Italy. In the early stages of her career, she worked at the Regina Elena National Cancer Institute of Rome, Italy studying pharmacokinetics of anti-cancer drugs. Later, she moved to Maryland where she became involved in serum biomarker discovery at SAIC-Frederick Inc. (now Leidos Biomedical Research). She is the Director of the Antibody Characterization Laboratory at the Frederick National Laboratory for Cancer Research since September 2019.